MicroStrategy
MSTR
Adobe
ADBE
Salesforce
CRM
Apple
AAPL
Meritage Homes
MTH
US Stock MarketDetailed Quotes
SRRK Scholar Rock
- 44.780
- +2.690+6.39%
Close Dec 20 16:00 ET
- 44.780
- 0.0000.00%
Post 20:05 ET
4.19BMarket Cap-18.97P/E (TTM)
45.840High41.535Low2.88MVolume41.760Open42.090Pre Close128.55MTurnover3.98%Turnover RatioLossP/E (Static)93.61MShares46.18552wk High52.93P/B3.24BFloat Cap6.76052wk Low--Dividend TTM72.40MShs Float70.000Historical High--Div YieldTTM10.23%Amplitude4.325Historical Low44.569Avg Price1Lot Size
About Scholar Rock Company
Scholar Rock Holding Corp. is a biopharmaceutical company. It engages in the business of discovering, developing, and delivering innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company was founded by Timothy A. Springer and Leonard I. Zon in October 2012 and is headquartered in Cambridge, MA.
Company Profile
SymbolSRRK
Company NameScholar Rock
Listing DateMay 24, 2018
Issue Price14.00
Founded2012
CEODr. Jay T. Backstrom, M.D.,M.P.H.
MarketNASDAQ
Employees150
Fiscal Year Ends12-31
Address301 Binney Street,3rd floor
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-857-259-3860
Websitehttp://www.scholarrock.com
Company Executives
- Name
- Position
- Salary
- Dr. Jay T. Backstrom, M.D.,M.P.H.
- Director, President and Chief Executive Officer
- 4.11M
- Mohammed Qatanani
- Chief Scientific Officer
- --
- Dr. Jing L. Marantz, M.D.,PhD
- Chief Medical Officer
- --
- Caryn Parlavecchio
- Chief Human Resources Officer
- --
- Edward H. Myles
- Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
- 2.01M
- Tracey Sacco
- Chief Commercial Officer
- 2.28M
- David L. Hallal
- Chairman of the Board
- 416.70K
- Kristina M. Burow
- Independent Director
- 300.34K
- Michael Gilman, PhD
- Independent Director
- 299.20K
- Dr. Srinivas Akkaraju, M.D.,PhD
- Independent Director
- 291.23K
- Dr. Jeffrey S. Flier, M.D.
- Independent Director
- 305.70K
- Amir H. Nashat, PhD
- Independent Director
- 295.70K
- Joshua Reed
- Independent Director
- 305.70K
- Dr. Akshay K. Vaishnaw, M.D.,PhD
- Independent Director
- 298.20K
- Richard H. Brudnick
- Independent Director
- 367.96K
- Katie Peng
- Independent Director
- --
- Junlin Ho
- General Counsel and Corporate Secretary
- --
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.